Michael Yellin

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi, Steven O’Day, David F. McDermott et al. · New England Journal of Medicine · 2010 · 15.2K citations · Full text

Medicine, Clinical Sciences, Oncology +12

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations

Medicine, Oncology, Pharmacology +13

Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4

Peter Attia, Giao Q. Phan, Ajay V. Maker et al. · Journal of Clinical Oncology · 2005 · 1K citations · Full text

Life Sciences, Immunology, Oncology +17

Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 4

Kimberly E Beck, Joseph Blansfield, Khoi Q. Tran et al. · Journal of Clinical Oncology · 2006 · 834 citations · Full text

Life Sciences, Immunology, Oncology +17

Prognostic Factors Related to Clinical Response in Patients with Metastatic Melanoma Treated by CTL-Associated Antigen-4 Blockade

Stephanie G. Downey, Jacob A. Klapper, Franz O. Smith et al. · Clinical Cancer Research · 2007 · 626 citations · Full text

Life Sciences, Immunology, Oncology +17